Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising Polyphenols in Parkinson’s Disease Therapeutics
Ashish Singh, Pratibha Tripathi, Arun Kumar Yadawa, et al.
Neurochemical Research (2020) Vol. 45, Iss. 8, pp. 1731-1745
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 162
Blood–Brain Barrier Permeable Photoacoustic Probe for High-Resolution Imaging of Nitric Oxide in the Living Mouse Brain
Zhiyong Jiang, Zhaolun Liang, Yijing Cui, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7952-7961
Closed Access | Times Cited: 57
Anti-inflammatory and Anti-oxidant Activity of Hidrox® in Rotenone-Induced Parkinson’s Disease in Mice
Rosalba Siracusa, Maria Scuto, Roberta Fusco, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 824-824
Open Access | Times Cited: 126
The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols
Sunisha Aryal, Taylor Skinner, Bronwyn Bridges, et al.
Molecules (2020) Vol. 25, Iss. 19, pp. 4382-4382
Open Access | Times Cited: 84
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 38
A Photoacoustic Probe with Blood‐Brain Barrier Crossing Ability for Imaging Oxidative Stress Dynamics in the Mouse Brain
Yijing Cui, Xiaoqing Wang, Zhiyong Jiang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 9
Closed Access | Times Cited: 26
Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10
The entrancing role of dietary polyphenols against the most frequent aging‐associated diseases
Muhammad Ajmal Shah, Hafiza Ishmal Faheem, Ayesha Hamid, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 235-274
Open Access | Times Cited: 21
Polyphenols Targeting MAP Kinase Signaling Pathway in Neurological Diseases: Understanding Molecular Mechanisms and Therapeutic Targets
Fahadul Islam, Sumon Roy, Mehrukh Zehravi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2686-2706
Closed Access | Times Cited: 19
Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
Camila de Oliveira Vian, Marcelo Augusto Germani Marinho, Magno da Silva Marques, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 3-22
Open Access | Times Cited: 6
Puerarin attenuates intracerebral hemorrhage‐induced early brain injury possibly by PI3K/Akt signal activation‐mediated suppression of NF‐κB pathway
Jun Zeng, Shizhong Zheng, Yizhao Chen, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 16, pp. 7809-7824
Open Access | Times Cited: 33
Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson’s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk
Shubhendu M. Shirgadwar, Rahul Kumar, Preeti Kumari, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S109-S124
Open Access | Times Cited: 26
Pyrazolamide derivatives inhibit α-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells
Li-Zi Xing, Wei Zhang, Yadong Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116198-116198
Closed Access | Times Cited: 5
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery
Yutian Ma, Palas B. Tiwade, Rachel VanKeulen-Miller, et al.
Nano Letters (2024) Vol. 24, Iss. 20, pp. 6092-6101
Open Access | Times Cited: 5
Potential therapeutic effects of curcumin, with or without L-DOPA, on motor and cognitive functions and hippocampal changes in rotenone-treated rats
Muaz Belviranlı, Nilsel Okudan, Tuğba Sezer
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Open Access
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation
Ahmed O. Abbas, Abdulaziz A. Alaqil, Hossam S. El‐Beltagi, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 893-893
Open Access | Times Cited: 33
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Musbau A. Akanji, Damilare Rotimi, Tobiloba Christiana Elebiyo, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 30
Valorization of Grape Pomace and Berries as a New and Sustainable Dietary Supplement: Development, Characterization, and Antioxidant Activity Testing
Adina Frum, Carmen Maximiliana Dobrea, Luca Liviu Rus, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3065-3065
Open Access | Times Cited: 22
Neuroprotective effect of YIAEDAER peptide against Parkinson’s disease like pathology in zebrafish
Qingyu Ren, Xin Jiang, Shanshan Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112629-112629
Open Access | Times Cited: 21
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Giulia Magni, Benedetta Riboldi, Katia Petroni, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115257-115257
Open Access | Times Cited: 21
Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of α-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress
Zhan Cui, Fangyan Guo, Li Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115965-115965
Closed Access | Times Cited: 12
Effect of NaCl stress germination on microstructure and physico-chemical properties of wheat starch
Ningjie Liang, Yining Pan, Dongyang Yang, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139924-139924
Closed Access
The Neuroprotective Effects of Agmatine on Parkinson’s Disease: Focus on Oxidative Stress, Inflammation and Molecular Mechanisms
Mohammad Yasin Zamanian, Mozhgan Nazifi, Lusine Khachatryan, et al.
Inflammation (2024)
Closed Access | Times Cited: 3
Luteolin Suppresses Microglia Neuroinflammatory Responses and Relieves Inflammation-Induced Cognitive Impairments
Wei Zhou, Mengmeng Hu, Jingrong Hu, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1800-1811
Closed Access | Times Cited: 22
The pharmacological basis of the curcumin nutraceutical uses: an update
Donatella Canistro, Annalisa Chiavaroli, Donatella Cicia, et al.
(2021) Vol. 03, Iss. 02, pp. 421-421
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top